Conference report: The IP counsel/ investor divide
“Despite the fact that we may have the utmost confidence in your patent estate, just settle.” That was how one investor advised IP counsel in the pharmaceutical and biotech industries
Owen Hughes, a director at Brookside Capital, told attendees of the BIO IP Counsels Committee Conference in New York last week that certainty is the chief goal of the investor community. That makes quick settlement far preferable to prolonged and...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.